AIDS

1. ANTWI S, Yang H, Enimil A, Martyn-Dickens C, et al
   Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV.
   AIDS. 2025;39:1668-1671.
   

   >> Share

   
   
2. DING Y, Li J, Gao C, Xing L, et al
   Machine learning algorithms to predict the risk of hyperlipidemia in people living with HIV after starting HAART for 6 months.
   AIDS. 2025 May 21. doi: 10.1097/QAD.0000000000004244.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

3. BOOPATHY AV, D'Antoni ML, Andreatta K, Chang S, et al
   Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Participants with Preexisting K65R/N in HIV-1 in Phase 2/3/3b Clinical Trials.
   J Acquir Immune Defic Syndr. 2025 Aug 8. doi: 10.1097/QAI.0000000000003742.
   

   >> Share

   
   
4. NUTT CT, Muyindike WR, Nanfuka V, Komukama N, et al
   Factors Associated with Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda.
   J Acquir Immune Defic Syndr. 2025 Aug 4. doi: 10.1097/QAI.0000000000003735.
   

   >> Share

   
   

   
   PLoS One

5. KAYINDA F, Awor P, Mahaba T, Muganzi AM, et al
   Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda: A cross-sectional study.
   PLoS One. 2025;20:e0320623.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share